Dear Colleagues,
A new program solicitation (RFA-AI-21-035) is now available:
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)
Please see https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-035.html for details.
Earliest submission date: June 02, 2021 following standard due date outlined in the FOA until July 07, 2023.
For timely responses to your questions, please direct your email messages to:
-------------------------------------------------------------
From the Program Solicitation:
The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory research focused on developing innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the infectious or immune-mediated disease research continuum aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation.
As a part of the trans-NIAID Data Science program, this R21 FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods, including artificial intelligence and machine learning approaches, that can considerably improve acquisition, management, analysis, visualization, and dissemination of relevant data and/or knowledge. This contrasts with early-stage development (U01) and enhancement/sustainment (U24) efforts to generate these tools and resources that are supported by the companion FOAs.
Estimated Number of Awards: NIAID intends to commit $1,040,000 in FY 2022 to fund up to 4 awards.